![]() ![]() ![]() Chemotherapy with or without radiation forms the basis of treatment of patients with recurrent and/or metastatic disease. Regardless of cancer subtype and HPV infection status, primary treatment with curative intent for patients with cervical cancer typically consists of surgery, chemoradiation, or a combination of these treatments options vary by cancer stage. 5, 6 Approximately 70% of cervical cancers are caused by persistent infection with high-risk (oncogenic) HPV type 16 or 18, 7 although persistence of other oncogenic HPV types (eg, 31, 33, 45, 52, 58) also confers an increased risk of cancer. 4 Persistent HPV infection is the most important factor in the development of cervical cancer. 3 Squamous cell carcinomas account for approximately 75% to 80% of all cervical cancers, and adenocarcinoma accounts for approximately 20%. It is the fourth most common cancer in women worldwide, with approximately 84% of cases occurring in developing countries, where cervical cancer is a leading cause of cancer death in women. 2 The estimated global yearly incidence of cervical cancer in 2018 was 570,000, with corresponding deaths of 311,000. 1 Although cervical cancer rates are decreasing overall among women in the United States, incidence remains elevated among Hispanic/Latino, Black, and Asian women. This activity is supported by an independent educational grant from Merck & Co., Inc.Īn estimated 13,800 new cases of cervical cancer will be diagnosed in the United States in 2020, and 4,290 people will die of the disease. This activity is supported by a medical education grant from Exelixis, Inc. ![]() This activity is supported by an independent medical education grant from Bristol-Myers Squibb. This activity is supported in part by an educational grant from Bayer Healthcare Pharmaceuticals. This activity is supported by educational grants from AstraZeneca Celgene Corporation Coherus BioSciences Genentech, a member of the Roche Group and TESARO, a GSK Company. To view all of the conflicts of interest for the NCCN Guidelines panel, go to /disclosures/guidelinepanellisting.aspx. Motter, PhD, Oncology Scientist/Medical Writer, NCCN, has disclosed that she has no relevant financial relationships. McMillian, MS, CHES, Guidelines Coordinator, NCCN, has disclosed that she has no relevant financial relationships.Īngela D. Yashar, MD, Panel Vice Chair, has disclosed that she has no relevant financial relationships. Abu-Rustum, MD, Panel Chair, has disclosed that he has received grant/research support from GRAIL and Stryker/Novadaq.Ĭatheryn M. Individuals Who Provided Content Development and/or Authorship Assistance: If you have any questions, please e-mail date: JExpiration date: June 10, 2021 Your credit cannot be reported without this information. Before completing these requirements, be sure your NCCN profile has been updated with your NAPB e-profile ID and date of birth. Continuing pharmacy education credit is reported to the CPE Monitor once you have completed the posttest and evaluation and claimed your credits. Pharmacists: You must complete the posttest and evaluation within 30 days of the activity. ![]() To participate in this journal CE activity: (1) review the educational content (2) take the posttest with a 66% minimum passing score and complete the evaluation at and (3) view/print certificate. UAN: JA4008196-7-H01-PĪll clinicians completing this activity will be issued a certificate of participation. Pharmacy (ACPE): NCCN designates this knowledge-based continuing education activity for 1.0 contact hour (0.1 CEUs) of continuing education credit. Nursing (ANCC): NCCN designates this educational activity for a maximum of 1.0 contact hour. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Medicine (ACCME): NCCN designates this journal-based CME activity for a maximum of 1.0 AMA PRA Category 1 Credit™. In support of improving patient care, National Comprehensive Cancer Network (NCCN) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |